A phase 2 trial investigates MRD detection and therapy advancements.
A recent meta-analysis reveals low persistence rates with anti-dementia drugs, highlighting factors influencing adherence and the need for standardized reporting.
In 2024, there is an urgent need for policies that will accelerate biosimilar use to achieve lower system-wide health care costs.
Physician outlines the process developed at The Ohio State University Comprehensive Cancer Center to help manage patient pain before, during, and after surgery without the use of opioids.
In Iraq, asymmetrical warfare tactics relied heavily on unconventional weaponry, requiring military physicians to improvise new medical techniques in order to increase rates of survival.
Differentiating between the 3 available options can help identify which is best for individual patients.
Using the term "pseudodementia" contributes to the mismanagement and mistreatment of the disease.
Managing transitions of care is vital to discontinue use of unnecessary drugs and minimize medication errors.
Pre-treatment DPYD genotyping significantly reduces hospitalizations and costs for patients with cancer, enhancing safety and efficiency in oncology care.
CKD is a complication of diabetes. Emerging treatments aim to optimize management and reduce risks. Pharmacists are key in applying new evidence to clinical practice.
Congress expected the FDA to draft a memorandum of understanding on interstate distributions of compounded medications that states would be willing to sign, but that’s not what the agency did.
A review of asthma guidelines, pharmacotherapy, and the role of the pharmacist.
This subset of heart failure requires unique therapeutic considerations.
This review summarizes current utilization of anti-HER2 targeted therapy across several non-breast solid tumors in the setting of advanced disease.
Four years after congress passed it, the Hannon Act is helping veterans get better care
Tisotumab vedotin-tftv is used as antitumor therapy for patients with disease progression during or after chemotherapy.
This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.
The COVID-19 pandemic has led to increased vigilance over the proper disposal of vaccine-related materials, such as vials, needles, syringes, and bandages.
Consider key elements of acute bacterial skin and skin structure infection to help patients manage this broad range of diseases.
Pharmacists are well suited to identify patients with dysphagia and educate patients and caregivers on when and how to safely crush and administer medication.
Ambulatory care pharmacy residents play a major role in increasing both patient awareness about recommended vaccination and vaccination rates.
Pharmacies cannot prevent shortages, particularly with the complexities of treating COVID-19; however, they can strengthen their ability to prepare their organization to respond to those complexities.
By combining the administration of psychedelic compounds with therapeutic support, ketamine-assisted therapy is proving remarkable efficacy in treating mental health conditions.
Curricula should require comprehensive training for providing contraceptive care, helping students perform duties confidently and competently.
The necessary push for the health care industry to move to whole-person care instead of condition-oriented models and tactics for applying a value-based model in pharmacy benefits.
FDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.
Osimertinib (Tagrisso; AstraZeneca) is FDA approved for 3 unique cancer indications.
Raising awareness of the potentially fatal cardiovascular complications of epinephrine toxicity.
Technicians can help prevent drug diversion, provide care for patients with opioid use disorder.